Report confirms 632x increase in Child Excess Deaths across Europe since
EMA approval of COVID Vaccine for Children
During week 21 of 2021, the European Medicines Agency extended the emergency use authorization of the Pfizer COVID-19 vaccine, first to children aged 12 to 15 and later to the age group of 5 to 11.
However, the weeks following the approval witnessed a shocking rise in excess deaths among children, an upward trend that persisted unabated.
Between week 22 of 2021 and week 52 of 2021, an alarming tally of 919 excess deaths among 0 to 14-year-old children should have sent shockwaves through the continent. But the data was suppressed.